O	0	6	Effect
O	7	9	of
O	10	12	an
B-intervention	13	24	information
I-intervention	25	32	leaflet
O	33	35	on
O	36	42	breast
O	43	49	cancer
O	50	59	screening
O	60	73	participation
O	73	74	:
O	75	76	A
O	77	84	cluster
O	85	95	randomized
O	96	106	controlled
O	107	112	trial
O	112	113	.

O	114	116	To
O	117	125	evaluate
O	126	129	the
O	130	136	impact
O	137	139	of
O	140	142	an
O	143	154	information
O	155	162	leaflet
O	163	168	about
O	169	172	the
O	173	177	risk
O	177	178	-
O	178	185	benefit
O	186	193	balance
O	194	196	of
O	197	203	breast
O	204	210	cancer
O	211	220	screening
O	221	223	on
O	224	229	women
O	229	230	'
O	230	231	s
O	232	245	participation
O	245	246	.

O	247	251	This
O	252	259	cluster
O	260	270	randomized
O	271	281	controlled
O	282	287	trial
O	288	291	was
O	292	301	conducted
O	302	308	within
O	309	310	a
O	311	321	population
O	321	322	-
O	322	327	based
O	328	334	breast
O	335	341	cancer
O	342	351	screening
O	352	359	program
O	360	363	and
O	364	372	included
O	373	378	women
O	379	383	from
O	384	387	the
O	388	397	catchment
O	398	403	areas
O	404	406	of
O	407	410	two
O	411	420	hospitals
O	421	423	in
B-location	424	433	Barcelona
I-location	433	434	,
I-location	435	440	Spain
O	440	441	.

O	442	444	We
O	445	454	evaluated
O	455	460	women
O	461	465	aged
B-age	466	468	50
I-age	468	469	-
I-age	469	471	69
I-age	472	477	years
O	478	485	invited
O	486	488	to
O	489	498	screening
O	499	506	between
O	507	516	September
O	517	521	2019
O	522	525	and
O	526	533	January
O	534	538	2020
O	538	539	.

O	540	543	The
O	544	556	intervention
O	557	562	group
O	563	571	received
O	572	574	an
O	575	586	information
O	587	594	leaflet
O	595	597	on
O	598	601	the
O	602	610	benefits
O	611	614	and
O	615	620	harms
O	621	623	of
O	624	635	mammography
O	636	645	screening
O	645	646	.

O	647	650	The
O	651	658	control
O	659	664	group
O	665	673	received
O	674	677	the
O	678	683	usual
O	684	694	invitation
O	695	701	letter
O	701	702	.

O	703	706	The
O	707	715	clusters
O	716	725	consisted
O	726	728	of
O	729	732	the
O	733	743	processing
O	744	748	days
O	749	751	of
O	752	755	the
O	756	766	invitation
O	767	773	letter
O	773	774	,
O	775	783	assigned
O	784	786	to
O	787	790	the
O	791	803	intervention
O	804	808	with
O	809	810	a
O	811	817	simple
O	818	824	random
O	825	835	allocation
O	836	842	scheme
O	842	843	.

O	844	846	We
O	847	855	compared
O	856	859	the
O	860	873	participation
O	874	878	rate
O	879	881	at
O	882	885	the
O	886	896	individual
O	897	902	level
O	903	910	between
O	911	917	groups
O	917	918	,
O	919	929	stratified
O	930	932	by
O	933	941	hospital
O	942	945	and
O	946	948	by
O	949	952	per
O	952	953	-
O	953	961	protocol
O	962	965	and
O	966	975	intention
O	975	976	-
O	976	978	to
O	978	979	-
O	979	984	treat
O	985	993	analyses
O	993	994	.

O	995	997	We
O	998	1006	included
B-total-participants	1007	1009	11
I-total-participants	1009	1010	,
I-total-participants	1010	1013	119
O	1014	1019	women
O	1020	1021	(
O	1021	1024	137
O	1025	1033	clusters
O	1033	1034	)
O	1034	1035	:
B-intervention-participants	1036	1040	5416
O	1041	1043	in
O	1044	1047	the
O	1048	1060	intervention
O	1061	1066	group
O	1067	1068	(
O	1068	1070	66
O	1071	1079	clusters
O	1079	1080	)
O	1081	1084	and
B-control-participants	1085	1089	5703
O	1090	1092	in
O	1093	1096	the
B-control	1097	1104	control
I-control	1105	1110	group
O	1111	1112	(
O	1112	1114	71
O	1115	1123	clusters
O	1123	1124	)
O	1124	1125	.

O	1126	1127	A
O	1128	1133	total
O	1134	1136	of
B-iv-bin-percent	1137	1139	36
I-iv-bin-percent	1139	1140	%
O	1141	1142	(
B-iv-bin-abs	1142	1146	1964
O	1146	1147	/
B-intervention-participants	1147	1151	5393
O	1151	1152	)
O	1153	1155	of
O	1156	1159	the
O	1160	1165	women
O	1166	1168	in
O	1169	1172	the
O	1173	1185	intervention
O	1186	1191	group
O	1192	1195	and
B-cv-bin-percent	1196	1198	37
I-cv-bin-percent	1198	1199	%
O	1200	1201	(
B-cv-bin-abs	1201	1205	2135
O	1205	1206	/
B-control-participants	1206	1210	5694
O	1210	1211	)
O	1212	1214	of
O	1215	1220	those
O	1221	1223	in
O	1224	1227	the
O	1228	1235	control
O	1236	1241	group
B-outcome	1242	1250	attended
I-outcome	1251	1260	screening
O	1260	1261	,
O	1262	1274	respectively
O	1274	1275	.

O	1276	1283	Overall
O	1283	1284	,
O	1285	1287	we
O	1288	1293	found
O	1294	1296	no
O	1297	1308	differences
O	1309	1311	in
B-outcome	1312	1325	participation
O	1326	1331	among
O	1332	1338	groups
O	1339	1340	(
O	1340	1350	difference
O	1351	1353	in
O	1354	1367	participation
O	1368	1369	-
O	1370	1371	1
O	1371	1372	.
O	1372	1373	1
O	1373	1374	%
O	1374	1375	;
O	1376	1378	95
O	1378	1379	%
O	1379	1381	CI
O	1381	1382	;
O	1383	1384	-
O	1385	1386	2
O	1386	1387	.
O	1387	1388	9
O	1389	1391	to
O	1392	1393	0
O	1393	1394	.
O	1394	1395	7
O	1395	1396	%
O	1396	1397	)
O	1397	1398	.

O	1399	1401	In
O	1402	1403	a
O	1404	1412	hospital
O	1413	1422	attending
O	1423	1424	a
O	1425	1435	population
O	1436	1440	with
O	1441	1442	a
O	1443	1446	low
O	1447	1460	socioeconomic
O	1461	1467	status
O	1467	1468	,
B-outcome	1469	1479	attendance
O	1480	1483	was
O	1484	1489	lower
O	1490	1492	in
O	1493	1496	the
O	1497	1509	intervention
O	1510	1515	group
O	1516	1517	(
O	1517	1518	-
O	1519	1520	1
O	1520	1521	.
O	1521	1522	4
O	1522	1523	,
O	1524	1526	95
O	1526	1527	%
O	1527	1529	CI
O	1529	1530	:
O	1531	1532	-
O	1533	1534	5
O	1534	1535	.
O	1535	1536	7
O	1536	1537	%
O	1538	1540	to
O	1541	1542	-
O	1543	1544	0
O	1544	1545	.
O	1545	1547	03
O	1547	1548	%
O	1548	1549	)
O	1549	1550	.

O	1551	1558	Overall
O	1559	1572	participation
O	1573	1575	in
O	1576	1579	our
O	1580	1587	program
O	1588	1591	was
O	1592	1602	unaffected
O	1603	1605	by
O	1606	1607	a
O	1608	1611	new
O	1612	1623	information
O	1624	1631	leaflet
O	1632	1634	on
O	1635	1638	the
O	1639	1643	risk
O	1643	1644	-
O	1644	1651	benefit
O	1652	1659	balance
O	1660	1662	of
O	1663	1669	breast
O	1670	1676	cancer
O	1677	1686	screening
O	1686	1687	.

O	1688	1695	However
O	1695	1696	,
O	1697	1710	participation
O	1711	1714	was
O	1715	1720	lower
O	1721	1723	in
O	1724	1731	certain
O	1732	1743	populations
O	1744	1748	with
O	1749	1754	lower
O	1755	1768	socioeconomic
O	1769	1775	status
O	1776	1781	TRIAL
O	1782	1794	REGISTRATION
O	1794	1795	:
O	1796	1801	Trial
O	1802	1814	registration
O	1815	1821	number
O	1822	1836	ISRCTN13848929
O	1837	1838	.
